Which cells have carbonic anhydrase

In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Suspensions of intact corpuscles tested by the usual colorimetric or manometric methods were found to be almost completely inactive. The activity of carbonic anhydrase within the red blood corpuscles, as well as its relationship to the chloride shift, were demonstrated spectroscopically by Keilin and Mann 2.

The bottle is fixed to a stationary shaking apparatus and its second aperture is connected by means of a three-way tap to the manometer. When the temperature is equilibrated, the taps are closed and the bottle is violently shaken and the manometer is read every 15 seconds.

The same procedure was adopted for the study of the liberation of carbon dioxide, the only difference being that the blood was first equilibrated with the gas mixture containing 5 per cent carbon dioxide and then transferred to the Woolf bottle containing pure nitrogen or pure oxygen. Meldrum, N. Article Google Scholar. Keilin, D. Mann, T. Roughton, F. Booth, C. Kroemer, G. Cancer Cell 13 , — Robey, I. Bicarbonate increases tumor pH and inhibits spontaneous metastases.

Huber, V. Proton dynamics in cancer. Hu, X. Central role of lactate and proton in cancer cell resistance to glucose deprivation and its clinical translation. Signal Transduct. Target Ther. Persi, E. Systems analysis of intracellular pH vulnerabilities for cancer therapy. Itel, F. CO 2 permeability of cell membranes is regulated by membrane cholesterol and protein gas channels. Arias-Hidalgo, M. Cholesterol is the main regulator of the carbon dioxide permeability of biological membranes.

Comparison of lactate transport in astroglial cells and monocarboxylate transporter 1 MCT 1 expressing Xenopus laevis oocytes. Expression of two different monocarboxylate transporters in astroglial cells and neurons. Characterization of the monocarboxylate transporter 1 expressed in Xenopus laevis oocytes by changes in cytosolic pH. Halestrap, A. The proton-linked monocarboxylate transporter MCT family: structure, function and regulation.

Dimmer, K. The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. Lambert, D. Molecular changes in the expression of human colonic nutrient transporters during the transition from normality to malignancy. Cancer 86 , — Mathupala, S. Silencing of monocarboxylate transporters via small interfering ribonucleic acid inhibits glycolysis and induces cell death in malignant glioma: an in vitro study.

Neurosurgery 55 , — Pinheiro, C. Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas. Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma. Histopathology 56 , — Hao, J. Cancer , — Role of monocarboxylate transporters in human cancers: state of the art. Dovmark, T. Connexin channels are a pathway for discharging lactate from glycolytic pancreatic ductal adenocarcinoma cells.

Oncogene 36 , — Swietach, P. The chemistry, physiology and pathology of pH in cancer. What is pH regulation, and why do cancer cells need it? Cancer Metastasis Rev. Andersen, A. Grinstein, S. EMBO J. Martin, C. Intracellular pH gradients in migrating cells. Ludwig, F. Protons extruded by NHE1: digestive or glue? Vahle, A. Extracellular matrix composition and interstitial pH modulate NHE1-mediated melanoma cell motility.

Martinez-Zaguilan, R. Ohta, T. Cancer 73 , — Lu, X. The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump. Hinton, A. Capecci, J. Cotter, K. Kulshrestha, A. Oncotarget 6 , — Xu, J. Carcinogenesis 33 , — Stransky, L.

The function of V-ATPases in cancer. McGuire, C. Regulation of V-ATPase activity. Landmark Ed 22 , — Boedtkjer, E.

Lee, S. Oncogene 37 , — Svastova, E. Carbonic anhydrase IX interacts with bicarbonate transporters in lamellipodia and increases cell migration via its catalytic domain.

Gorbatenko, A. Regulation and roles of bicarbonate transporters in cancer. Hypoxia optimises tumour growth by controlling nutrient import and acidic metabolite export. Aspects Med.

Hypoxia and cellular metabolism in tumour pathophysiology. Humphreys, B. Functional characterization and regulation by pH of murine AE2 anion exchanger expressed in Xenopus oocytes. Stewart, A. Regulation of AE2 anion exchanger by intracellular pH: critical regions of the NH 2 -terminal cytoplasmic domain. Alper, S. Putative re-entrant loop 1 of AE2 transmembrane domain has a major role in acute regulation of anion exchange by pH. Aronson, P. Wakabayashi, S. Lacroix, J. EMBO Rep. Paris, S. Bourguignon, L.

Busco, G. Lucien, F. PLoS One 6 , e Amith, S. Mboge, M. Carbonic anhydrases: role in pH control and cancer. Metabolites 8 , 19 PubMed Central Google Scholar. Pastorekova, S.

Caner Ther. Frost, S. Tolvanen, M. Analysis of evolution of carbonic anhydrases IV and XV reveals a rich history of gene duplications and a new group of isozymes. Aspatwar, A. Phylogeny and expression of carbonic anhydrase-related proteins. BMC Mol. Carbonic anhydrase related proteins: molecular biology and evolution. Subcell Biochem. Pastorek, J. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment.

Oncogene 9 , — Parkkila, A. Immunohistochemical demonstration of human carbonic anhydrase isoenzyme II in brain tumours. Saarnio, J. Karhumaa, P. Yoo, C. Carbonic anhydrase XII expression is associated with histologic grade of cervical cancer and superior radiotherapy outcome. Zheng, Y. CA1 contributes to microcalcification and tumourigenesis in breast cancer.

BMC Cancer 15 , 1—15 Zhou, Y. Carbonic anhydrase II mediates malignant behavior of pulmonary neuroendocrine tumors. Respir Cell Mol. Wang, D. Carbonic anhydrase 1 is a promising biomarker for early detection of non-small cell lung cancer. Tumour Biol. Parkkila, S. Carbonic anhydrase II. A novel biomarker for gastrointestinal stromal tumors.

Pathol 23 , — Gastroenterology , — Ivanov, S. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer.

Genomics 33 , — Alterio, V. Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX. Natl Acad. USA , — Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: From biology to clinical use.

Cancer 82 , — Csaderova, L. The effect of carbonic anhydrase IX on focal contacts during cell spreading and migration. Innocenti, A. The proteoglycan region of the tumor-associated carbonic anhydrase isoform IX acts as anintrinsic buffer optimizing CO 2 hydration at acidic pH values characteristic of solid tumors. Ames, S. The proteoglycan-like domain of carbonic anhydrase IX mediates non-catalytic facilitation of lactate transport in cancer cells. Oncotarget 9 , — Wykoff, C.

Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Kaluz, S. Kopacek, J. MAPK pathway contributes to density- and hypoxia-induced expression of the tumor-associated carbonic anhydrase IX. Acta - Gene Struct. Liao, S. Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas.

Giatromanolaki, A. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.

Loncaster, J. Carbonic anhydrase CA IX expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Potter, C. These isozymes have some sequence variations leading to specific differences in their activity. Thus isozymes found in some muscle fibers have low enzyme activity compared to that secreted by salivary glands.

While most carbonic anhydrase isozymes are soluble and secreted, some are bound to the membranes of specific epithelial cells.

For a deeper look at carbonic anhydrase from a genomic perspective, please visit the Protein of the Month feature at the European Bioinformatics Institute. Inhibitor green bound in the active site of carbonic anhydrase. Since this enzyme produces and uses protons and bicarbonate ions, carbonic anhydrase plays a key role in the regulation of pH and fluid balance in different parts of our body.

In our stomach lining it plays a role in secreting acid, while the same enzyme helps to make pancreatic juices alkaline and our saliva neutral. The transport of the protons and bicarbonate ions produced in our kidney and eyes influence the water content of the cells at these locations.

Thus carbonic anhydrase isozymes perform different functions at their specific locations, and their absence or malfunction can lead to diseased states, ranging from the loss of acid production in the stomach to kidney failure.

When there is a build up of fluid that maintains the shape of our eyes, the fluid often presses on the optic nerve in the eye and may damage it. This condition is called glaucoma. In recent years, inhibitors of carbonic anhydrase are being used to treat glaucoma. Blocking this enzyme shifts the fluid balance in the eyes of the patient to reduce fluid build up thereby relieving pressure.

The structure of PDB entry 1cnw shows how one such inhibitor a sulfonamide , colored green in the figure, is bound to human carbonic anhydrase isozyme II. Note that this inhibitor binds near the active site and disrupts the interactions of the water bound to the zinc ion, blocking the enzyme action. Unfortunately, prolonged use of this drug can affect the same enzyme present in other tissues and lead to side effects like kidney and liver damage. Topics for Further Discussion Carbonic anhydrase is an example of a "perfect" enzyme, which performs its reaction as fast as carbon dioxide molecules can diffuse to it.

You can find other diffusion-limited enzymes in the PDB archive, including catalase , superoxide dismutase , and triosephosphate isomerase. IUCrJ 5, Journal of Biological Chemistry , Pharmacology and Therapeutics 74, EMBO Journal 15, Journal of Medicinal Chemistry 38, About Molecule of the Month.